Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.7M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
14M
-
Shares change
-
-12.8M
-
Total reported value, excl. options
-
$83.2M
-
Value change
-
-$76.1M
-
Put/Call ratio
-
0.23
-
Number of buys
-
52
-
Number of sells
-
-2
-
Price
-
$5.96
Significant Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q2 2023
62 filings reported holding WGS - GeneDx Holdings Corp. - Common Stock as of Q2 2023.
GeneDx Holdings Corp. - Common Stock (WGS) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14M shares
of 28.7M outstanding shares and own 48.56% of the company stock.
Largest 10 shareholders include Corvex Management LP (3.31M shares), Casdin Capital, LLC (3.1M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.25M shares), ORACLE INVESTMENT MANAGEMENT INC (866K shares), Blackstone Inc. (835K shares), MARSHALL WACE, LLP (761K shares), Soleus Capital Management, L.P. (711K shares), VANGUARD GROUP INC (679K shares), GAGNON SECURITIES LLC (364K shares), and BlackRock Inc. (263K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.